bioMerieux SA to Gradually Close its Boxtel Site in the Netherlands, Job Cuts

MARCY L'ETOILE, France--(BUSINESS WIRE)--Regulatory News:

bioMérieux (Paris:BIM) announced that it will phase out activities at its Boxtel site in the Netherlands by the end of 2009. The site develops and manufactures reagents for molecular biology and immunoassay microplate product lines.

bioMérieux remains committed to develop and support the products currently manufactured at Boxtel, recognizing the important role they play in public health. Information on the transfer of current activities from Boxtel to other locations will be communicated at a later date.

287 employees work at the Boxtel site today. bioMérieux will make every effort to support employees through this period.

In an initial estimation, this decision will result in the recognition of a non-recurring charge of approximately €32 million in the 2007 financial results.

About bioMérieux

Advancing Diagnostics to Improve Public Health

A world leader in the field of in vitro diagnostics for over 40 years, bioMérieux is present in more than 150 countries through 35 subsidiaries and a large network of distributors. In 2006, revenues reached €1.037 billion with 83% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software), which determine the source of disease and contamination to improve patient health and ensure consumer safety. Our products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on Euronext Paris. For more information, visit www.biomerieux.com.

Contacts

bioMérieux Investor Relations bioMérieux Hervé Laurent Tel: + 33 4 78 87 22 37 investor.relations@eu.biomerieux.com or LT Value Nancy Levain Tel: + 33 1 55 27 15 88 nancy.levain@ltvalue.com or Media Relations bioMérieux Image Sept Koren Wolman-Tardy Tel: + 33 4 78 87 20 08 media@eu.biomerieux.com or Laurence Heilbronn Tel: + 33 1 53 70 74 64 lheilbronn@image7.fr or Tiphaine Hecketsweiler Tel: + 33 1 53 70 74 59 thecketsweiler@image7.fr

MORE ON THIS TOPIC